Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL2 | P60568 | 5/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.48 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.48 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | JAK1 | P23458 | 1/20 | 0.46 |
| ▸ | TYK2 | P29597 | 1/20 | 0.46 |
| ▸ | WNT3A | P56704 | 1/20 | 0.45 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 3/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL450224 | 0.99 | IL2 (0.55) | IL2L3MBTL1ABCB1ABCC1JAK2 | |
| SCHEMBL449982 | 0.93 | IL2 (0.63) | IL2ABCB1ABCC1WNT3ADEGS1 | |
| SCHEMBL439102 | 0.87 | ABCB1 (0.49) | IL2ABCB1ABCC1WNT3ADEGS1 | |
| SCHEMBL11911923 | 0.83 | IL2 (0.65) | IL2 | |
| SCHEMBL2847557 | 0.82 | ABCB1 (0.58) | IL2ABCB1ABCC1WNT3ADEGS1 | |
| SCHEMBL2310680 | 0.81 | IL2 (0.54) | IL2 | |
| SCHEMBL4768204 | 0.81 | IL2 (0.60) | IL2ABCB1JAK2JAK1TYK2 | |
| SCHEMBL452378 | 0.80 | IL2 (0.66) | IL2ABL1 | |
| SCHEMBL2305750 | 0.79 | IL2 (0.56) | IL2ABL1 | |
| SCHEMBL8239294 | 0.78 | IL2 (0.67) | IL2L3MBTL1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239819-A | Method for preparing 4-halogenated-3-fluorotoluene | 沈阳中化农药化工研发有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-117658831-A | Preparation method of m-hydroxylamine intermediate 2-amino-1- (3- (benzyloxy) phenyl) propanol | 天津科盛医药技术有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-113387903-A | Synthesis method of parecoxib sodium impurity | 宏冠生物药业有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-112778203-A | Process for the preparation of 1H-indazole-3-carboxylic acid derivatives and granisetron and lonidamine | 兰州交通大学 | 2021-05-11 | — | — | CN | claimed |
| CN-111943878-A | Benzo beta-lactam and preparation method thereof | 兰州交通大学 | 2020-11-17 | — | — | CN | claimed |
| US-20120064121-A1 | PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES | SYNTA PHARMACEUTICALS CORP. (MA) | 2012-03-15 | — | — | US | claimed |
| EP-2182808-A1 | PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES | Synta Pharmaceuticals Corporation (US) | 2010-05-12 | — | — | EP | claimed |
| US-20090054527-A1 | Administration of capsaicinoids | ALGORX (US) | 2009-02-26 | — | — | US | claimed |
| WO-2009017819-A1 | PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES | SYNTA PHARMACEUTICALS CORP. (US) | 2009-02-05 | — | — | WO | claimed |
| EP-1587506-A4 | ADMINISTRATION OF CAPSAICINOIDS | ALGORX (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1587506-A2 | ADMINISTRATION OF CAPSAICINOIDS | Algorx (US) | 2005-10-26 | — | — | EP | claimed |
| US-20040156931-A1 | Administration of capsaicinoids | ALGORX | 2004-08-12 | — | — | US | claimed |
| WO-2004056305-A2 | ADMINISTRATION OF CAPSAICINOIDS | ALGORX (US) | 2004-07-08 | — | — | WO | claimed |
| US-5646181-A | ORGANIC NITRITE COMPOUNDS | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1997-07-08 | — | — | US | claimed |
| US-5489610-A | TREATING CONDITIONS SUCH AS ANGINA PECTORIS, ISCHEMIC DISEASES, CONGESTIVE HEART FAILURE, CONTROLLING HYPERTENSION AND IMPOTENCE IN MALE PATIENTS | RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 1996-02-06 | — | — | US | claimed |
| CN-113166004-B | Method for preparing 5-bromo-1, 3-dichloro-2-fluorobenzene | 巴斯夫欧洲公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118239819-A | Method for preparing 4-halogenated-3-fluorotoluene | 沈阳中化农药化工研发有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-5489610-A | TREATING CONDITIONS SUCH AS ANGINA PECTORIS, ISCHEMIC DISEASES, CONGESTIVE HEART FAILURE, CONTROLLING HYPERTENSION AND IMPOTENCE IN MALE PATIENTS | RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 1996-02-06 | — | — | US | disclosed |
| US-5208002-A | METHOD OF PRODUCING ALKALI METAL AZIDES | NIPPON CARBIDE KOGYO KABUSHIKI KAISHA (JP) | 1993-05-04 | — | — | US | disclosed |
| EP-0514143-A1 | Method of producing alkali metal azides | NIPPON CARBIDE KOGYO KABUSHIKI KAISHA (JP) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064121-A1 | PYRIDINE COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES | IL5, CXCR3, TSLP | IL2 24/4885L3MBTL1 4278/4885ABCB1 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.